We are live on !
Find out more
EC
EntryPoint Capital Portfolio holdings
AUM
$412M
Turnover
50.4%
1-Year Est. Return
28.52%
This Fund
S&P 500
This Quarter Est. Return
+15.49%
1 Year Est. Return
+28.52%
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$412M
AUM Growth
+$70.8M
(+21%)
Cap. Flow
+$36.5M
Cap. Flow % of AUM
Cap. Flow %
8.87%
Top 10 Holdings %
Top 10 Hldgs %
4.34%
Holding
1,002
New
271
Increased
170
Reduced
168
Closed
234
Avg Time Held
0.4
years
Top 10 Avg Time Held
0
years
Top 20 Avg Time Held
0.1
years
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Huntington Bancshares
HBAN
|
+$1.67M |
| 2 |
Donaldson
DCI
|
+$1.6M |
| 3 |
FedEx
FDX
|
+$1.6M |
| 4 |
Fidelity National Financial
FNF
|
+$1.53M |
| 5 |
Graco
GGG
|
+$1.51M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Cadence Design Systems
CDNS
|
+$1.48M |
| 2 |
TIC Solutions Inc
TIC
|
+$1.48M |
| 3 |
Schrodinger
SDGR
|
+$1.27M |
| 4 |
Exelon
EXC
|
+$1.23M |
| 5 |
Visteon
VC
|
+$1.22M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Industrials | 18% |
| 2 | Financials | 16.8% |
| 3 | Healthcare | 15.07% |
| 4 | Technology | 12.86% |
| 5 | Consumer Discretionary | 9.22% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
101
Marriott International
MAR
$102B
| $918K | 0.22% |
+2,477
| New | +$913K |
2026 Q2
0 quarters
|
|
102
Southern Company
SO
$103B
| $916K | 0.22% |
+9,568
| New | +$901K |
2026 Q2
0 quarters
|
|
103
Fortinet
FTNT
$126B
| $916K | 0.22% |
+5,960
| New | +$689K |
2026 Q2
0 quarters
|
|
104
Arch Capital
ACGL
$34.3B
| $911K | 0.22% |
9,389
+5,400
| +135% | +$509K |
2025 Q3
3 quarters
|
|
105
Sempra
SRE
$53.4B
| $911K | 0.22% |
9,821
| – | – |
2026 Q1
1 quarter
|
|
106
Conagra Brands
CAG
$6.69B
| $900K | 0.22% |
66,838
+21,504
| +47% | +$300K |
2025 Q4
2 quarters
|
|
107
Upstream Bio Inc
UPB
$153M
| $896K | 0.22% |
129,446
+55,878
| +76% | +$468K |
2026 Q1
1 quarter
|
|
108
Erie Indemnity
ERIE
$12.7B
| $894K | 0.22% |
+3,730
| New | +$855K |
2026 Q2
0 quarters
|
|
109
Wells Fargo
WFC
$246B
| $892K | 0.22% |
+10,799
| New | +$868K |
2026 Q2
0 quarters
|
|
110
Littelfuse
LFUS
$9.8B
| $889K | 0.22% |
+1,952
| New | +$845K |
2026 Q2
0 quarters
|
|
111
Charles Schwab
SCHW
$155B
| $886K | 0.22% |
+9,602
| New | +$876K |
2026 Q2
0 quarters
|
|
112
News Corp Class A
NWSA
$16.2B
| $880K | 0.21% |
35,422
-25,465
| -42% | -$660K |
2025 Q4
2 quarters
|
|
113
PACS Group
PACS
$7.25B
| $877K | 0.21% |
20,573
+4,010
| +24% | +$144K |
2025 Q4
2 quarters
|
|
114
XPO
XPO
$21.7B
| $877K | 0.21% |
4,273
+2,921
| +216% | +$618K |
2026 Q1
1 quarter
|
|
115
Otis Worldwide
OTIS
$27B
| $871K | 0.21% |
12,159
+9,417
| +343% | +$703K |
2025 Q1
5 quarters
|
|
116
Prudential Financial
PRU
$39.2B
| $870K | 0.21% |
+8,057
| New | +$819K |
2026 Q2
0 quarters
|
|
117
Jefferies Financial Group
JEF
$10B
| $864K | 0.21% |
17,290
-18,121
| -51% | -$934K |
2025 Q1
5 quarters
|
|
118
AtriCure
ATRC
$2.83B
| $863K | 0.21% |
30,831
+10,950
| +55% | +$308K |
2025 Q1
5 quarters
|
|
119
Ultragenyx Pharmaceutical
RARE
$1.48B
| $860K | 0.21% |
25,766
-353
| -1% | -$8.77K |
2026 Q1
1 quarter
|
|
120
NWPX Infrastructure Inc
NWPX
$941M
| $859K | 0.21% |
+5,726
| New | +$627K |
2026 Q2
0 quarters
|
|
121
TriMas Corp
TRS
$1.41B
| $850K | 0.21% |
18,868
+4,252
| +29% | +$169K |
2026 Q1
1 quarter
|
|
122
Regency Centers
REG
$13.3B
| $848K | 0.21% |
10,630
| – | – |
2026 Q1
1 quarter
|
|
123
West Pharmaceutical
WST
$27B
| $847K | 0.21% |
2,360
+729
| +45% | +$223K |
2026 Q1
1 quarter
|
|
124
Kinsale Capital Group
KNSL
$8.33B
| $846K | 0.21% |
+2,564
| New | +$825K |
2026 Q2
0 quarters
|
|
125
United Community Banks
UCB
$4.07B
| $845K | 0.21% |
24,092
| – | – |
2025 Q1
5 quarters
|
|
Similar funds
KP
T
HP
WIP
MP
AWP
THCM
KWM
EntryPoint Capital's Q2 2026 Portfolio in Review
As of Q2 2026, EntryPoint Capital held 1,002 positions worth $412M, up 21% from $341M the previous quarter. Its ten largest holdings account for 4.3% of the portfolio.
EntryPoint Capital deployed $36.5M of net new capital in Q2 2026, opening 271 new positions and adding to 170 existing holdings. Its largest new stake was Huntington Bancshares: 101,010 shares worth $1.79M.
By sector, the portfolio is most concentrated in Industrials at 18% of assets, down from 19% a quarter earlier, followed by Financials and Healthcare.
On the sell side, the largest reduction was Cadence Design Systems, an estimated $1.48M trimmed.
- EntryPoint Capital's largest Q2 2026 buy was Huntington Bancshares: 101,010 shares worth $1.79M.
- EntryPoint Capital added most to Gilead Sciences in Q2 2026, an estimated $1.51M increase.
- EntryPoint Capital's biggest Q2 2026 reduction was Cadence Design Systems, cutting an estimated $1.48M.
- EntryPoint Capital fully exited Exelon in Q2 2026, selling an estimated $1.23M.
- EntryPoint Capital's ten largest holdings make up 4.3% of its $412M portfolio in Q2 2026.
- EntryPoint Capital opened 271 new positions and closed 234 in Q2 2026.
- EntryPoint Capital's portfolio value rose 21% quarter-over-quarter to $412M.
Based on EntryPoint Capital's 13F filing for Q2 2026, filed 13 Aug 2026.